Tandem Diabetes Care Inc(TNDM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:04 AM ET (Korea 9/11 20:04)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.93 | Insider Own | 1.24% | Shs Outstand | 69.5M | Perf Week | -10.94% |
| Market Cap | 1.27B | Forward P/E | 129 | EPS next Y | 121.15% | Insider Trans | -0.02% | Shs Float | 68.7M | Perf Month | -21.89% |
| Enterprise Value | 1.56B | PEG | - | EPS next Q | -0.24 | Inst Own | 114.33% | Short Float | 15.4% | Perf Quarter | 12.82% |
| Income | -0.06B | P/S | 1.22 | EPS this Y | 54.02% | Inst Trans | -0.31% | Short Ratio | 5.5 | Perf Half Y | -17.37% |
| Sales | 1.04B | P/B | 9.77 | EPS next 5Y | - | ROA | -6.24% | Short Interest | 10.59M | Perf YTD | -16.7% |
| Book/sh | 1.88 | P/C | 2.79 | EPS past 3/5Y | -27.3% -40.1% | ROE | -48.03% | 52W High | -38.25% ($29.65) | Perf Year | 48.02% |
| Cash/sh | 6.55 | P/FCF | - | Sales past 3/5Y | 8.22% 15.27% | ROIC | -7.45% | 52W Low | 59.77% ($11.46) | Perf 3Y | -22.05% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 70.03% | Gross Margin | 55.99% | Volatility(W/M) | 4.99% 4.93% | Perf 5Y | -85.07% |
| Dividend TTM | - | EV/Sales | 1.5 | Sales Y/Y TTM | 3.92% | Oper. Margin | -4.17% | ATR (14) | 1.12 | Perf 10Y | -74.5% |
| Dividend Ex-Date | - | Quick Ratio | 2.65 | EPS Q/Q | 60.75% | Profit Margin | -6.08% | RSI (14) | 33.57 | Recom | 1.96 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.18 | Sales Q/Q | 5.59% | SMA20 | -14.77% ($21.48) | Beta | 1.65 | Target Price | $29.16 |
| Payout | - | Debt/Eq | 5.67 | Earnings | 2026/8/6 | SMA50 | -5.36% ($19.35) | Rel Volume | 0.83 | Prev Close | $19.11 |
| Employees | 2500 | LT Debt/Eq | 5.51 | EPS/Sales Surpr. | 4.37% -0.17% | SMA200 | -7.45% ($19.78) | Avg Volume(3M) | 1.92M | Price | $18.31 |
| IPO | 2013/11/14 | Option/Short | Yes/Yes | Trades | 12230 | Volume | 1,588,001 | Change | -4.19% |
Company
TNDM is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💉 Tandem Diabetes Care (TNDM) is a US medical device company that develops insulin pumps and automated insulin delivery systems for diabetes patients. The company has established a strong presence in the type 1 and type 2 diabetes management market with its flagship t:slim insulin pump and the compact Tandem Mobi pump, with its automated algorithms that integrate with continuous glucose monitors serving as its core competitive advantage.
Over the past 1 year, roughly in the middle
38% below its 1-year high.
TNDM has weak earning power
Review management risk carefully before investing
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +54.0% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -22.1% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 114.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
ACVT 0.02%
XHE 0.02%
APPC 0.01%
HEAL 0.01%
MATE 0.01%It ranks #4 in the industry
Based on market cap of $1B.
TNDM $1B PER -
ABT $179B PER 33.4
MDT $117B PER 22.6
SYK $104B PER 28.0
FAQ
What kind of company is TNDM?
TNDM belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of TNDM?
The market cap of TNDM is approximately $1.3B, ranking 2,454 within its sector.
What is the 52-week high and low for TNDM?
TNDM has recorded a 52-week high of $29.65 and a low of $11.46.
